Skip to content

Our nanoforming technologies, formulation and analytical services span the full range of drug development from small-molecule to large-molecule therapeutics. We accelerate your time to clinic while also increasing possibilities and probabilities of success in taking your product to market by developing the optimal nanoformulation.

small-molecules-logo-transp
gSmall Molecules Logo

Small molecules

Our multi-patented Controlled Expansion of Supercritical Solutions (CESS®) technology enables the creation of API nanoparticles directly from solution. The process can be applied to most small molecules, with a high success rate.

biologics-logo-transp

Biologics

Our biological nanoforming technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. It’s effectiveness has been demonstrated on proteins in the 1-150 kDa range, and it is capable of engineering particle sizes to specific requirements.

formulation-logo-transp

Formulation

Our experienced formulation development team designs and develops flexible dosage forms of nanoformed drug substances to meet preclinical and clinical development as well as life-cycle needs. Our dosage forms cover oral, parenteral, ophthalmic and inhaled therapies and more.

gmp-logo-transp

GMP Manufacturing

We have GMP manufacturing capabilities for the manufacture of nanoformed clinical-grade API’s (Active Pharmaceutical Ingredients) for our customers and partners.

STARMAP®

Our STARMAP® online platform leverages cutting-edge sparse-data AI to pick winners among candidate molecules that are predicted to be best amenable to CESS®-powered nanoforming and that exhibit optimal production characteristics.

Case studies

Our multi-patented Controlled Expansion of Supercritical Solutions (CESS®) technology can enable the creation of uniform small-molecule API nanoparticles as small as 10 nm directly from solution.